Researchers report that declining PPP2R5C levels in blood may signal early Alzheimer’s pathology, offering new insight into tau regulation and future diagnostic strategies Study: Neuronal PPP2R5C in plasma is a potential biomarker for early diagnosis of Alzheimer’s disease In a recent study published in the journal Cell Reports Medicine, researchers identified protein phosphatase 2 regulatory subunit … Read more
Emerging evidence suggests widely used metabolic drugs could influence brain aging pathways, yet large clinical trials are still needed to confirm whether they truly alter the course of neurodegenerative disease. Study: The promise of GLP-1 receptor agonists for neurodegenerative diseases. Image Credit: Antonio Marca / Shutterstock In a recent review published in the Journal of Clinical … Read more
Even though aging is the largest risk factor for Parkinson’s disease, the majority of research aimed at taming the able neurodegenerativeincur motor disease has largely left aging out of the mix. A group of researchers from around the globe seek to change that. “Unraveling the intersection of aging and Parkinson’s disease: a collaborative road map … Read more